🇺🇸 FDA
Patent

US 9802927

Oxadiazine compounds and methods of use thereof

granted A61KA61K31/535A61P

Quick answer

US patent 9802927 (Oxadiazine compounds and methods of use thereof) held by DENALI THERAPEUTICS INC. expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/535, A61P, A61P25/28